Regulations.gov document
Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests Guidance for Test…
Other · FDA-2020-D-0987 · posted Feb 22, 2021
Key facts
| Document ID | FDA-2020-D-0987-0061 |
|---|---|
| Title | Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests Guidance for Test Developers and Food and Drug Administration Staff February 2021 |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2020-D-0987 |
| Posted | Feb 22, 2021 |
| Comment period opens | Feb 22, 2021 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: